Founded in July 2011, with personalized diagnosis and treatment of cardiovascular, tumor as the strategic direction, Wuhan YZY Medical Science and Technology Co., Ltd. (YZY Med)is a high-tech enterprise specializing in the R&D, production and sales of individualized medical diagnostic products. The company has established various technical platforms, including ARMS fluorescence quantitative PCR, multiple fluorescence quantitative PCR, nucleic acid mass spectrometry, fluorescence in situ hybridization(FISH) and circulating tumor cell detection, etc. Meanwhile, the  self-developed products include molecular diagnostic products to guide personalized medicine for cardiovascular and cerebrovascular diseases, companion diagnostic products to guide tumor diagnosis and treatment, FISH products and circulating tumor cell (CTC) Autoanalyzer System, all these provide clinical diagnosis basis for precision medicine.The company has successfully developed over 160 genetic diagnostic products and multiple in vitro diagnostic (IVD) devices since 2014, among which 14 molecular diagnostic kits have obtained Medical Device Registration Certificates in Class III by National Medical Products Administration (NMPA) in China.